Frontiers in oncology.

natarajan bhaskaran. Sri Ramachandra Institute of Higher Education and Research. Chennai, India. Associate Editor. Pharmacology of Anti-Cancer Drugs. This section explores high-quality research concerning all aspects of cancer and benign neoplasm drug treatment.Feb 1, 2024 ... The upcoming scientific Forum titled "New Frontiers in Cancer and Healthy Aging," organized by IBSA Foundation for Scientific Research in ... Here, introducing Frontiers in Oncology: Quarterly Highlights, we feature a collection of carefully selected articles published during the first quarter of 2019 across the different sections. With a record number of papers to choose from, the papers enclosed in this Special Edition highlight some of the recent advances across the different ... Oct 22, 2023 ... Results from the ongoing phase Ib/II BEGONIA platform trial support the promise of the anti-TROP2 ADC datopotamab deruxtecan in combination with ...

Treatment effect on contrast-enhanced tumor (CET) was evaluated according to the response assessment in neuro-oncology (RANO) criteria for clinical trials . In addition, an automated software-based method developed in house was used to objectively calculate the CET volume (see below and Supplementary Appendix ).

They should provide the following: 1) Discuss current advances and future directions, 2) Clear presentation of the authors’ perspective, 3) Accurate presentation and citations of other authors’ work, 4) May include original data as well as personal insights and opinions.The official journal of the International Union of Immunological Societies (IUIS) and the most cited in its field, leading the way for research across basic, translational and clinical immunology.

Nov 15, 2022 ... "Structure Matters: A Call to Action," presented by Robert A. Winn, MD, Director and Lipman Chair in Oncology, VCU Massey Cancer Center. Artificial Intelligence (AI) has many possible applications in Oncology. One of the most promising is the potential for AI to represent and/or infer processes from real-world data. On one hand, the availability of the pattern of care is growing in opportunities (e.g. new markers, devices, drugs, etc.), constraints (guidelines, protocols, legal issues), and needs (e.g. investments, sustainable ... Strauss GM, Herndon JE 2nd, Maddaus MA, Johnstone DW, Johnson EA, Harpole DH, et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage ib non-small-cell lung cancer: calgb 9633 with the cancer and leukemia group B, radiation therapy oncology group, and north central cancer treatment group study groups.Some hardships faced by frontier farmers were a lack of rainfall and dense earth that was difficult to plow, owing to the tough grasses of the Great Plains. Preprint repository name [Preprint] (2008). Available at: https://persistent-url (Accessed March 15, 2018). Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies.

Phx to chicago

penelope jayne duerksen-hughes. Loma Linda University. Loma Linda, United States. Associate Editor. Gynecological Oncology. Part of a multidisciplinary journal, this section explores the development of a personalized and tailored approach to the prevention and treatment of gynecologic malignancies.

Aims and scope. Frontiers in Oncology is a broad-scope, multidisciplinary journal covering all areas of cancer research to advance our knowledge of cancer epidemiology to improve diagnosis ...The Cancer Genetics specialty section will facilitate the publication of high-quality original research and review articles pertaining to the genetic, genomic and molecular aspects of cancer, and technical advances that facilitate progress in this field. Focused primarily on molecular genetic aberrations driving malignant processes in human ...The Pediatric Oncology section of Frontiers in Oncology aims to provide fair and rapid peer review in order to publish scientific advances for the benefit of all members of the pediatric oncology community, from basic scientists, to clinical researchers, and to caregivers. Pediatric Oncology has experienced great successes in the last 40 years ...4 days ago · Yu Zhu. Jixiang Chu. Dan Luo. Hai-Long Dai. Chengde Liao. Frontiers in Oncology. doi 10.3389/fonc.2024.1394708. This section advances our understanding of thoracic malignancies, namely pleural tumors, thymic malignancies, lung and mediastinal tumors, lung carcinoids, chest wall tumors and tracheal tumors. Frontiers in Oncology. doi 10.3389/fonc.2024.1370059. 249 views Original Research. Published on 26 Apr 2024 Predictors of radiation-induced late rectal toxicity in prostate cancer treatment: a volumetric and dosimetric analysis. in Radiation Oncology. Simon K. B. Spohn;Guohui Cao. Hongtao Zhang. Juan Wang. Frontiers in Oncology. doi 10.3389/fonc.2024.1339955. 304 views. Part of a multidisciplinary journal, this section explores the impact of genetic aberrations in carcinogenesis, as well as in the progression and outcomes of cancer.

Institute of Molecular Pathology Biomarkers, University of Extremadura. Cáceres, Spain. Specialty Chief Editor. Pharmacogenetics and Pharmacogenomics.priya ranjit bhosale. University of Texas MD Anderson Cancer Center. Houston, United States. Associate Editor. Gynecological Oncology.Frontiers in Oncology Molecular and Cellular Oncology Research Topics. 365 Days of Progress In Molecular and Cellular Oncology. 6.5K. views. 22. authors. 4. …3 Department of Pathology and Laboratory Medicine, Brown University Warren Alpert Medical School, Providence, RI, United States. Editorial on the Research Topic. Expert opinions in genitourinary oncology. In the last decade we have seen an explosion in the development of new treatment options, diagnostic tools, and prognostic and predictive ...Telemedicine in Oncology: Delivering on an Overdue Promise in the COVID-19 Era. Telemedicine has historically been underutilized in medicine broadly, and specifically in oncology, despite the general availability of the needed infrastructure to offer it as a platform for remote care. The COVID-19 pandemic posed new risks of infection …

Marry M. van den Heuvel-Eibrink. Archie Bleyer. Frontiers in Oncology. doi 10.3389/fonc.2024.1336714. 838 views. Part of a multidisciplinary journal, this section publishes quality basic science, translational studies, and clinical trials in the field of pediatric oncology.Safeguarding peer review to ensure quality at scale. Making scientific research open has never been more important. But for research to be trusted, it must be of the highest quality. Facing an industry-wide rise in fraudulent science, Frontiers has increased its focus on safeguarding quality. PRESS RELEASE.

Female breast cancer (BC) has surpassed lung cancer and today it is the most diagnosed type of cancer (2.3 million new cancer cases, representing 11.7% of all cancer cases). In terms of mortality, it ranks in 5 th place, with 685,000 deaths in 2020. For women, BC represents 1 in 4 cancer cases and accounts for 1 in 6 cancer deaths ( 1 ).1 Introduction. The human epidermal growth factor receptor protein tyrosine kinase family, including EGFR and HER2, has emerged as an important therapeutic target for non-small cell lung cancer, breast cancer, and gastroesophageal cancer (1, 2).In NSCLC, EGFR exon 20 insertions mutations account for 1.5-2.5% of all NSCLC, 6% of …We currently have eight national consortia agreements and partnerships with more than 650 institutions across the world who support the Frontiers editorial program. Check if your institution has a payment plan with us. Part of a multidisciplinary journal, this section explores new insights into the distribution, etiology, prevention ...If you’re in the market for a reliable and versatile off-road vehicle, then look no further than the Nissan Frontier 4×4. With its rugged design, powerful performance, and advanced...Aram Boada. Anna Martinez-Cardús. Alan Chu. Zongwen Liu. Jose Luis Manzano. Frontiers in Oncology. doi 10.3389/fonc.2024.1322116. 783 views. Part of a multidisciplinary journal, this section expands our understanding of molecular and cellular mechanisms involved in skin cancer progression.Introduction. Non-communicable Diseases (NCD) were responsible for 15 million premature deaths (30-69 years) worldwide in 2016, with more than 85% of these deaths occurring in low- and middle …Immunobiology and Immunotherapeutics in Myelodysplastic Syndrome and Acute Myeloid Leukemia. Shyam Patel. Anna Aureli. Alessandro Isidori. Claudio Cerchione. 2,536 views. 2 articles. Part of a multidisciplinary journal, this section explores all aspects of hematological malignancies, including acute and chronic leukemia, lymphoma and plasma and ...This section provides broad mechanistic and translational insights into all aspects of cancer and its interaction with components of the tumor-microenvironment.

Meta keywords

2.1 Characterization of Resistance in Cancer. Drug resistance in cancer is an intimate occurrence that results when cancer becomes tolerant of pharmaceutical treatment ().An extensive range of factors contributes to the development of resistance against anticancer drugs, including genetic mutations, altered epigenetics, enhanced drug efflux, …

The Nutritional Science Research Group issues a quarterly electronic newsletter, Nutrition Frontiers, that highlights emerging evidence linking diet to ...francesco giovinazzo. Unit of General and Liver Transplant Surgery, Department of Medical and Surgical Sciences, Agostino Gemelli University Polyclinic (IRCCS) Rome, Italy. Specialty Chief Editor. Surgical Oncology.Frontiers requires manuscripts submitted to meet international English language standards to be considered for publication. For authors who would like their manuscript to receive language editing or proofreading to improve the clarity of the manuscript and help highlight their research, we recommend the language-editing services provided by the following external partners.zhe-sheng chen. Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John’s University. newyork, United States. Specialty Chief Editor. Cancer Cell Signaling.Are you an oncology nurse looking to expand your knowledge and advance your career? Look no further than free online oncology nursing CEU courses. Online learning has revolutionize...timothy james kinsella. Department of Radiation Oncology, Warren Alpert Medical School, Brown University. Providence, United States. Specialty Chief Editor. Radiation Oncology.Effect of different treatment modalities on the prognosis of patients with stage IIIC cervical cancer. Xiaoman Su. Jiazhen Huang. Ning Wang. Frontiers in Oncology. doi 10.3389/fonc.2024.1405778. Highlights research in carcinogenesis and tumor progression, bridging the gap between basic research and clinical applications to advance diagnosis ...See all (43) Learn more about Research Topics. This section explores molecular and clinical characteristics of a broad group of malignancies with special interest on the biology and therapeutic strategies for head and neck cancer subtypes.Mohamed Rahouma. Massimo Baudo. Magdy M. El-Sayed Ahmed. Frontiers in Oncology. doi 10.3389/fonc.2023.1271452. 776 views. Part of a forward-thinking journal, this section covers the entire emerging interface between cardiovascular medicine and oncology.Female breast cancer (BC) has surpassed lung cancer and today it is the most diagnosed type of cancer (2.3 million new cancer cases, representing 11.7% of all cancer cases). In terms of mortality, it ranks in 5 th place, with 685,000 deaths in 2020. For women, BC represents 1 in 4 cancer cases and accounts for 1 in 6 cancer deaths ( 1 ).

Tracess B Smalley. Timothy H Tran. Frontiers in Oncology. doi 10.3389/fonc.2024.1394702. Part of a multidisciplinary journal, this section explores targetable intervenients in cancer signaling pathways and their application in drug development and therapeutics.Updates on Radiation-induced Lymphopenia. Peter Sylvain Nicolas van Rossum. Steven H Lin. Jian-Yue Jin. 14,906 views. 9 articles. Part of a multidisciplinary journal, this section explores personalized cancer treatments focusing on advancements in information in cancer biology.Frontiers has a community retraction protocol in place to retract papers where serious concerns have been raised and validated by the community that warrant retraction, including ethical concerns, honest errors or scientific misconduct. Explores research into the molecular and cellular mechanisms of carcinogenesis and cancer progression.Instagram:https://instagram. which actor you look like Scope. The field of radiation oncology is currently entering a new frontier of more personalized cancer treatment. We are being led into this new frontier by the explosion of information in cancer biology. From the maturation of 3-dimensional (3-D) to 4- dimensional (4-D) photon and proton radiation planning and delivery, and the refinement of ... simply drawn Treatment effect on contrast-enhanced tumor (CET) was evaluated according to the response assessment in neuro-oncology (RANO) criteria for clinical trials . In addition, an automated software-based method developed in house was used to objectively calculate the CET volume (see below and Supplementary Appendix ). clear chrome browser cache Frontiers operates a single-blind model during the review process. This means the reviewers know who the authors are in order to offer a full assessment within the context of their research and to ensure they can avoid any potential competing interests in accepting a review invitation. Frontiers also believes that reviewers should be ...Dec 21, 2023 · Perspective: rethinking therapeutic strategies in oncology. Immuno-oncology has revolutionized cancer care, drug development, the design of clinical trials, standard treatment paradigms, and the evaluation of response to therapy. These are all areas, however, that have not fully incorporated principles of tumor immunology. mgmrewards.com login Research Topics. This section explores basic science, translational and clinical aspects of Cancer Metabolism, with a particular emphasis on energy metabolism and metabolic reprogramming in cancer cells.Breast Cancer is a specialty section of Oncology dedicated to advancing scientific and clinical knowledge of breast cancers. This section seeks to publish articles addressing novel findings, controversies, and innovative hypotheses in the areas of prevention, diagnosis, and treatment of early breast lesions and breast malignancies. army men toy Here, introducing Frontiers in Oncology: Quarterly Highlights, we feature a collection of carefully selected articles published during the first quarter of 2019 across the different sections. With a record number of papers to choose from, the papers enclosed in this Special Edition highlight some of the recent advances across the different disciplines.See all (158) Learn more about Research Topics. Part of a multidisciplinary journal, this section explores all aspects of hematological malignancies, including acute and chronic leukemia, lymphoma and plasma and hematopoietic stem cell disorders. how to make voice message Frontiers in Oncology is a broad-scope, multidisciplinary journal covering all areas of cancer research to advance our knowledge of cancer epidemiology to improve diagnosis, …4 days ago · timothy james kinsella. Department of Radiation Oncology, Warren Alpert Medical School, Brown University. Providence, United States. Specialty Chief Editor. Radiation Oncology. ron howard cocoon The best modem for Frontier DSL is the Actiontec 300 Mbps, a Frontier-compatible modem with rating of four out of five stars on Amazon.com. Other Frontier-compatible modems include...The Pediatric Oncology section of Frontiers in Oncology aims to provide fair and rapid peer review in order to publish scientific advances for the benefit of all members of the pediatric oncology community, from basic scientists, to clinical researchers, and to caregivers. Pediatric Oncology has experienced great successes in the last 40 years ...Master protocols in oncology allow detection of specific signal pathways strongly associated with driver gene mutations, cancer cell growth, and progression . A basket trial is a particular type of master protocol that evaluates the efficacy and safety of a targeted therapy in multiple diseases that share a common molecular alteration ( 11 ) or ... ver anime gratis harry burke. Uniformed Services University of the Health Sciences. Bethesda, United States. Associate Editor. Cancer Molecular Targets and Therapeutics. Part of a multidisciplinary journal, this section explores targetable intervenients in cancer signaling pathways and their application in drug development and therapeutics.3. Segmentation: To achieve reliable radiomic models in oncology, robustly and precisely delineating lesions is essential. However, traditional manual segmentation usually takes a very long time to perform, generates interobserver variability, and requires the involvement of experienced radiologists for analysis. dickson electric system Frontiers in Oncology ... Sodium-Glucose Co-Transporter 2 Inhibitors May Change the Development of Urinary Tract and Hematological Malignancies as Compared With ... newark to mumbai flight Artificial Intelligence (AI) has many possible applications in Oncology. One of the most promising is the potential for AI to represent and/or infer processes from real-world data. On one hand, the availability of the pattern of care is growing in opportunities (e.g. new markers, devices, drugs, etc.), constraints (guidelines, protocols, legal issues), and needs (e.g. investments, sustainable ...Immunobiology and Immunotherapeutics in Myelodysplastic Syndrome and Acute Myeloid Leukemia. Shyam Patel. Anna Aureli. Alessandro Isidori. Claudio Cerchione. 2,536 views. 2 articles. Part of a multidisciplinary journal, this section explores all aspects of hematological malignancies, including acute and chronic leukemia, lymphoma and plasma and ... www.new york times wordle 本文介绍了瑞士期刊《Frontiers in Oncology》的发展历程、影响因子、发文量、审稿速度、版面费等情况，以及该刊的优缺点和投稿建议。该刊是一本涵盖肿瘤癌症各个领域的开 …May 10, 2024 · Marry M. van den Heuvel-Eibrink. Archie Bleyer. Frontiers in Oncology. doi 10.3389/fonc.2024.1336714. 838 views. Part of a multidisciplinary journal, this section publishes quality basic science, translational studies, and clinical trials in the field of pediatric oncology. bipul r acharya. Cedars Sinai Medical Center. Los Angeles, United States. Associate Editor. Molecular and Cellular Oncology.